The Plumb reads the noise, grades the evidence, and tells you what actually matters. No hype. No tribes.
The morning briefing
One evidence-graded read each morning. No hype, no tribes.
Who wants to live forever?
A drug built to reverse the age of cells has, for the first time, been put into a human. It went into an eye — and what that does and doesn't mean is the whole story.
Is London Calling?
Two years of obituaries, mostly written on a millionaire-exodus figure its own authors keep quietly revising down. Underneath the gloom, the money is already moving back.
👍 0Where do grey-market peptides actually come from?
Bulk powder from Chinese chemical plants, labelled 'research only' to clear customs, paid for in crypto, and policed not by any regulator but by a single lab that fails nearly half of what it tests.
👍 0The peptides the NHS won't prescribe
Two-year waits and four-figure clinics have pushed thousands into a fast-moving grey market. How it works, who's really in it, and what's coming next.
👍 1,290Can the US switch off your AI overnight?
Build your country or company on a closed American model and access can vanish, by export control, sanction, or a single policy memo. The fix nobody mentions is about who actually holds the model.
👍 876Why I run five coding agents and trust none of them
Pick a favourite coding agent and you've already lost the plot. The way to actually ship is to run several, challenge everything, and trust none of them yet.
👍 540Is extreme wealth actually new?
People rage at the super-rich as if it were a 21st-century invention. It's one of the oldest patterns there is.
👍 430What is success — and will you pay the price?
Obsession, years of daily execution, and a dose of luck the gurus never mention. An honest look at the cost.
👍 312Lift heavy or run far?
For a longer life, the research is less either/or than the gym tribes insist. What actually moves the needle.
👍 221